CLINICAL_TRIALS
trial_result
· 2025-12-18
Clinical Trial Update: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy [Phase 2]
Summary
Phase 2 trial of tanimilast in uncontrolled asthma patients on ICS background maintenance was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Uncontrolled Asthma | Phase 2 | Status: TERMINATED